Tricida, Inc. Banner Image

Tricida, Inc. has reached its limit for free report views

Work for Tricida, Inc.? Upgrade Your Profile and unlock all your annual reports.

Tricida, Inc.

  • Ticker TCDA
    Exchange NASDAQ More
  • Industry Drug Manufacturers - Major More
  • Sector Healthcare More
Tricida, Inc. Logo Image
  • 51-200 Employees
  • Based in South San Francisco, California
Tricida, Inc. is a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with CKD. Tricida is currently conducting the VALOR-CKD clinical trial to evaluate the efficacy and safety of veverimer in delaying CKD progressionMore in subjects with metabolic acidosis. There are no FDA-approved treatments for chronic metabolic acidosis.
4.8 / 5.0 (212)

Tricida, Inc. reports have an aggregate usefulness score of 4.8 based on 212 reviews.

Tricida, Inc.

Most Recent Annual Report

Tricida, Inc.
MOST RECENT 2021 Annual Report and Form 10K

Report Locked. Tricida, Inc. has reached its limit for free report views.

Older/Archived Annual Reports

Tricida, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!